NANOVIRICIDES, INC. Retained Earnings
NANOVIRICIDES, INC. (NNVC) had Retained Earnings of -$154.84 million as of 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-05-15
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$154.84M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$152.85M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$150.63M.
- 2025-06-30: Retained Earnings (Accumulated Deficit) -$148.84M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-03-31 | -$154.84M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | -$152.85M 10-Q · filed 2026-02-17 | |
| 2025-09-30 | -$150.63M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | -$148.84M 10-Q · filed 2026-05-15 | |
| 2025-03-31 | -$146.75M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | -$144.53M 10-Q · filed 2025-02-14 | |
| 2024-09-30 | -$142.50M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | -$139.37M 10-K · filed 2025-09-29 | |
| 2024-03-31 | -$137.02M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | -$135.16M 10-Q · filed 2024-02-14 | |
| 2023-09-30 | -$133.05M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | -$131.08M 10-K · filed 2024-09-27 | |
| 2023-03-31 | -$127.51M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | -$125.81M 10-Q · filed 2023-02-14 | |
| 2022-09-30 | -$124.06M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$122.49M 10-K · filed 2023-10-13 | |
| 2022-03-31 | -$120.71M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | -$118.92M 10-Q · filed 2022-02-14 | |
| 2021-09-30 | -$117.00M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | -$114.39M 10-K · filed 2022-10-13 | |
| 2021-03-31 | -$112.31M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | -$110.20M 10-Q · filed 2021-02-16 | |
| 2020-09-30 | -$107.87M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | -$105.56M 10-K · filed 2021-10-12 | |
| 2020-03-31 | -$103.69M 10-Q · filed 2020-06-22 | |
| 2019-12-31 | -$95.61M 10-Q · filed 2020-02-14 | |
| 2019-09-30 | -$93.68M 10-Q · filed 2019-11-15 | |
| 2019-06-30 | -$92.12M 10-K · filed 2020-10-13 | |
| 2019-03-31 | -$89.90M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | -$87.76M 10-Q · filed 2019-02-14 | |
| 2018-09-30 | -$85.53M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | -$83.69M 10-K · filed 2019-08-23 | |
| 2018-03-31 | -$82.04M 10-Q · filed 2018-05-21 | |
| 2017-12-31 | -$79.93M 10-Q · filed 2018-02-20 | |
| 2017-09-30 | -$77.13M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | -$75.13M 10-K · filed 2018-10-12 | |
| 2017-03-31 | -$72.57M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | -$69.43M 10-Q · filed 2017-02-14 | |
| 2016-09-30 | -$67.89M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | -$64.82M 10-K · filed 2017-09-28 | |
| 2016-03-31 | -$63.17M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | -$58.18M 10-Q · filed 2016-02-09 | |
| 2015-09-30 | -$55.41M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | -$54.10M 10-K · filed 2016-09-16 | |
| 2015-03-31 | -$53.18M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | -$52.93M 10-Q · filed 2015-02-25 | |
| 2014-09-30 | -$51.05M 10-Q/A · filed 2015-02-23 | $52.65M 10-Q · filed 2014-11-14 |
| 2014-06-30 | -$51.90M 10-K · filed 2015-09-14 | $52.41M 10-K · filed 2014-09-30 |
| 2014-03-31 | -$44.90M 10-Q · filed 2015-05-15 | |
| 2013-12-31 | -$46.22M 10-Q · filed 2015-02-25 | |
| 2013-09-30 | -$44.86M 10-Q/A · filed 2015-02-23 | |
| 2013-06-30 | $38.30M 10-K · filed 2014-09-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |